Assessing and validating reliable change across ADNI protocols

dc.contributor.authorHammers, Dustin B.
dc.contributor.authorKostadinova, Ralitsa
dc.contributor.authorUnverzagt, Frederick W.
dc.contributor.authorApostolova, Liana G.
dc.contributor.authorAlzheimer’s Disease Neuroimaging Initiative
dc.contributor.departmentNeurology, School of Medicine
dc.date.accessioned2024-02-01T16:08:29Z
dc.date.available2024-02-01T16:08:29Z
dc.date.issued2022
dc.description.abstractObjective: Reliable change methods can aid in determining whether changes in cognitive performance over time are meaningful. The current study sought to develop and cross-validate 12-month standardized regression-based (SRB) equations for the neuropsychological measures commonly administered in the Alzheimer's Disease Neuroimaging Initiative (ADNI) longitudinal study. Method: Prediction algorithms were developed using baseline score, retest interval, the presence/absence of a 6-month evaluation, age, education, sex, and ethnicity in two different samples (n = 192 each) of robustly cognitively intact community-dwelling older adults from ADNI - matched for demographic and testing factors. The developed formulae for each sample were then applied to one of the samples to determine goodness-of-fit and appropriateness of combining samples for a single set of SRB equations. Results: Minimal differences were seen between Observed 12-month and Predicted 12-month scores on most neuropsychological tests from ADNI, and when compared across samples the resultant Predicted 12-month scores were highly correlated. As a result, samples were combined and SRB prediction equations were successfully developed for each of the measures. Conclusions: Establishing cross-validation for these SRB prediction equations provides initial support of their use to detect meaningful change in the ADNI sample, and provides the basis for future research with clinical samples to evaluate potential clinical utility. While some caution should be considered for measuring true cognitive change over time - particularly in clinical samples - when using these prediction equations given the relatively lower coefficients of stability observed, use of these SRBs reflects an improvement over current practice in ADNI.
dc.eprint.versionAuthor's manuscript
dc.identifier.citationHammers DB, Kostadinova R, Unverzagt FW, Apostolova LG; Alzheimer’s Disease Neuroimaging Initiative*. Assessing and validating reliable change across ADNI protocols. J Clin Exp Neuropsychol. 2022;44(2):85-102. doi:10.1080/13803395.2022.2082386
dc.identifier.urihttps://hdl.handle.net/1805/38271
dc.language.isoen_US
dc.publisherTaylor & Francis
dc.relation.isversionof10.1080/13803395.2022.2082386
dc.relation.journalJournal of Clinical and Experimental Neuropsychology
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectReliable change
dc.subjectAssessment
dc.subjectNeuropsychology
dc.subjectPractice effects
dc.subjectMemory
dc.titleAssessing and validating reliable change across ADNI protocols
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nihms-1815821.pdf
Size:
633.38 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: